Company News
Director dealings: M&C Saatchi chair invests, Staffline director linked to transactions
M&C Saatchi was on the list of director buys on Monday after its executive chair bought 70,000 shares in two separate transactions.
Shares in S4 Capital tank as guidance lowered again, 500 jobs axed
Shares in Martin Sorrell's S4 Capital tanked by almost a third on Monday as the digital advertising agency cut full-year earnings guidance again and axed 500 jobs as clients pull spending over recession fears.
Hermogenyx shares soar on new partnership with Prevail Partners
Shares in biopharma group Hemogenyx surged on Monday after the company received a $0. 83m investment from Prevail Partners as it continues to work on its planned clinical trial for leukaemia treatment.
BP Marsh upbeat ahead of Kentro shareholding sale
Financial services venture capital investor BP Marsh said in an update on Monday that it was selling its shareholding in Kentro, a London-based insurance group, for £51. 5m, pending regulatory approvals.
Zenova delivers first FX500 extinguishers to US market
Zenova Group announced the successful first deliveries of 13,654 units of its Zenova FX500 handheld aerosol extinguishers for the American market on Monday.
TPXimpact offloads Questers in £7.5m deal
Technology services firm TPXimpact confirmed on Monday that it has finalised the sale of Questers Resourcing and Questers Bulgaria, collectively known as Questers, to Pwrteams.
Vast Resources announces delay to historic panel settlement
Mining company Vast Resources updated the market on the announcement it made on 7 August on Monday regarding the recovery of the historic parcel.
Vast Resources announces delay to settlement of historic parcel
Mining company Vast Resources updated the market on the announcement it made on 7 August on Monday regarding the recovery of the historic parcel.
Greencoat Renewables reports solid first-half performance
Greencoat Renewables reported a significant increase in electricity generation and net cash generation for its first half on Monday.
Advanced Medical Solutions inks new US partnership
Tissue-healing technology specialist Advanced Medical Solutions announced a partnership with TELA Bio on Monday, which it described as a pioneering medical technology company renowned for its innovative soft-tissue reconstruction solutions.
Elixirr posts strong growth, announces Responsum acquisition
Challenger consultancy Elixirr International reported strong first-half growth in its interim results and announced the acquisition of US-based AI specialist Responsum on Monday.
GCP Infrastructure terminates merger discussions with GABI
GCP Infrastructure Investments has ceased discussions about a proposed merger with GCP Asset Backed Income Fund (GABI), it announced on Monday, with the initial heads of terms (HoTs) between the two entities terminated.
Diversified Energy shuffles executives as finance chief steps down
Diversified Energy announced a number of changes to its executive leadership structure on Monday, as its executive vice-president and chief financial officer Eric Williams stepped down with immediate effect to explore new professional avenues.
Phoenix Group smashes forecasts with cash generation
Savings and retirement group Phoenix lifted its interim dividend by 5% after smashing forecasts with cash generation in the first half.
Pendragon sells UK motor, leasing arm for £250m
Car dealership operator Pendragon on Monday said it was selling its UK motor and leasing business to US firm Lithia for £250m.
HICL Infrastructure sells interest in Bradford schools PFI
HICL Infrastructure announced the sale of its equity interests in the ‘Bradford Building Schools for the Future’ (BSF) first and second phase public finance initiative projects on Monday, for an estimated £37m.
US FDA approves GSK treatment for myelofibrosis
GSK announced on Monday that the US Food and Drug Administration (FDA) has granted approval for ‘Ojjaara’, or momelotinib, as a treatment for adults suffering from intermediate or high-risk myelofibrosis with anaemia, including cases of primary myelofibrosis or secondary myelofibrosis.